Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography
In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State
Mammography: Panel Member Quits Over “One-Sided” Document
AACR Calls For Clear Statement; Says Report Was “Premature”
Research Funding: Clinton Proposes 2.6% Increase For NIH, Amount Called “Paltry”
National Action Plan: Return $14 Million To NCI, Committee Tells Shalala
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- CBER Director Vinay Prasad dared to “say no to drugs”
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”









